Document is current
Any future updates will be listed below
-
Authors
Teuschl, Yvonne https://orcid.org/0000-0002-1755-7943
Fanciulli, Alessandra https://orcid.org/0000-0002-2854-4179
Pavy-Le Traon, Anne https://orcid.org/0000-0002-9375-1553
Habek, Mario https://orcid.org/0000-0002-3360-1748
Thijs, Roland D. https://orcid.org/0000-0003-1435-8970
Pavelic, Antun R.
Struhal, Walter https://orcid.org/0000-0001-7360-7784
-
Funding
Funding for this research was provided by:
Karl Landsteiner Privatuniversität für Gesundheitswissenschaften
- License Information
-
More Information
Article History
Received: 19 June 2024
Accepted: 26 November 2024
First Online: 9 January 2025
Declarations
:
: R.D.T. reports consultancy and speakers’ fees from Union Chimique Belge, LivAssured, Angelini, GlaxoSmithKline, Theravance, Novartis, and Zogenix as well as grants from Medtronic and New Life Wearables. The other authors declare that they have no conflict of interest.
